Which similar companies made leadership changes around the same time?

Aculys Pharma (April 1, 2024), Orsini Specialty Pharmacy (April 4, 2024), Parexel (March 18, 2024) and Arcutis (April 10, 2024) also announced leadership changes within 45 days of TransCode Therapeutics.

TransCode Therapeutics Appoints Daniel Vlock, M.D. as Chief Medical Officer

PUBLIC · RNAZMar 28, 2024

Company

TransCode Therapeutics

BostonBiotechnologyHealth CareMedicalTherapeutics

Description

TransCode Therapeutics, Inc. has appointed Daniel Vlock, M.D. as the company’s Chief Medical Officer

Quick answer

TransCode Therapeutics Appoints Daniel Vlock, M.D. as Chief Medical Officer (March 28, 2024). TransCode Therapeutics is based in Boston, Massachusetts, United States.

What did TransCode Therapeutics announce on March 28, 2024?: TransCode Therapeutics, Inc. has appointed Daniel Vlock, M.D. as the company’s Chief Medical Officer
What does TransCode Therapeutics do?: TransCode is an RNA oncology company created on the belief that cancer can be more effectively treated using RNA therapeutics.
Where is TransCode Therapeutics based?: TransCode Therapeutics is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?: Aculys Pharma (April 1, 2024), Orsini Specialty Pharmacy (April 4, 2024), Parexel (March 18, 2024) and Arcutis (April 10, 2024) also announced leadership changes within 45 days of TransCode Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Aculys Pharma Appoints Hidemasa Tanigaki as Chief Executive Officer and Representative Director (April 1, 2024)
Orsini Specialty Pharmacy Welcomes Victor Haddock as Chief Financial Officer and Lynda Parker as Executive Vice President of Trade Relations and Account Management (April 4, 2024)
Parexel Appoints Peyton Howell as Chief Executive Officer (CEO) to Succeed Jamie Macdonald (March 18, 2024)
Arcutis Biotherapeutics Appoints David Topper as Chief Financial Officer (April 10, 2024)
ELIAS Animal Health Appoints Brian Segebrecht as Chief Revenue Officer (April 10, 2024)
BioMarin Appoints Cristin Hubbard as Chief Commercial Officer (March 8, 2024)

Who to call at TransCode Therapeutics, and when

A new leader at TransCode Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

An alert the day TransCode Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at TransCode Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TransCode Therapeutics. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TransCode Therapeutics

Location

Boston, Massachusetts, United States

About

TransCode is an RNA oncology company created on the belief that cancer can be more effectively treated using RNA therapeutics. Using its proprietary iron oxide nanoparticle delivery platform, the company has created a portfolio of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes. The company’s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which is believed to cause approximately 90% of all cancer deaths totaling over nine million per year worldwide. Another of the company’s drug candidates, TTX-siPDL1, focuses on treating tumors by targeting a protein called Programmed death-ligand 1 (PD-L1). TransCode also has three cancer-agnostic programs: TTX-RIGA, an RNA–based agonist of the retinoic acid-inducible gene I designed to drive an immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9–based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines designed to activate cytotoxic immune responses against tumor cells.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TransCode Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans